Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 10:14:1306290.
doi: 10.3389/fendo.2023.1306290. eCollection 2023.

Interactions between COVID-19 infection and diabetes

Affiliations
Review

Interactions between COVID-19 infection and diabetes

Hassan M Heshmati. Front Endocrinol (Lausanne). .

Abstract

Coronavirus disease 2019 (COVID-19) caused a major pandemic affecting human health and economy around the world since the beginning of 2020. The virus responsible for the disease is "severe acute respiratory syndrome coronavirus 2" (SARS-CoV-2). It invades the target cells by binding to angiotensin-converting enzyme 2 (ACE2). ACE2 is expressed in several organs including endocrine glands. Multiple endocrine and metabolic systems including the endocrine pancreas have been impacted by COVID-19 infection/pandemic. COVID-19 pandemic can promote obesity through alterations in lifestyle (e.g., unhealthy diet and reduced physical activity due to confinement and isolation) leading to type 2 diabetes and/or can directly impair the function of the endocrine pancreas particularly through a cytokine storm, promoting or aggravating type 1 or type 2 diabetes. The increased ACE2 receptors of high adiposity commonly associated with type 2 diabetes and the chronic hyperglycemia of diabetes with its negative impact on the immune system can increase the risk of COVID-19 infection and its morbidity/mortality. In conclusion, there are bidirectional interactions between COVID-19 pandemic and diabetes (e.g., COVID-19 infection can impact diabetes and diabetes can impact COVID-19 infection). The services offered by healthcare systems for the management of diabetes have been adapted accordingly.

Keywords: COVID-19 infection; angiotensin-converting enzyme 2; coronavirus; diabetes; immune system; pandemic.

PubMed Disclaimer

Conflict of interest statement

Author HMH is affiliated with Endocrinology Metabolism Consulting, LLC, Hassan Heshmati and Valerie Shaw Endocrine Research.

Figures

Figure 1
Figure 1
SARS-CoV-2. Copyright phonlamai (Kittipong Jirasukhanont)/Depositphotos Inc.
Figure 2
Figure 2
Diabetes negatively impacts several organs. Copyright edesignua (Tetiana Zhabska)/Depositphotos Inc.

References

    1. Sahin AR, Erdogan A, Mutlu Agaoglu P, Dineri Y, Cakirci AY, Senel ME, et al. . 2019 Novel coronavirus (COVID-19) outbreak: a review of the current literature. Eurasian J Med Oncol (2020) 4:1–7. doi: 10.14744/ejmo.2020.12220 - DOI
    1. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun (2020) 109:102433. doi: 10.1016/j.jaut.2020.102433 - DOI - PMC - PubMed
    1. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China. Challenges for global health governance. JAMA (2020) 323:709–10. doi: 10.1001/jama.2020.1097 - DOI - PubMed
    1. Woolf SH, Chapman DA, Lee JH. COVID-19 as the leading cause of death in the United States. JAMA (2021) 325:123–4. doi: 10.1001/jama.2020.24865 - DOI - PMC - PubMed
    1. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest (2020) 43:1027–31. doi: 10.1007/s40618-020-01276-8 - DOI - PMC - PubMed

MeSH terms

Substances